In Vitro Susceptibility Testing of Clinical Isolates of Chlamydia trachomatis
1993

Testing Antibiotics Against Chlamydia trachomatis

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): Mark G. Martens, Sebastian Faro, Maurizio Maccato, Gerald Riddle, Hunter Hammill, Y. Wang

Primary Institution: Baylor College of Medicine

Hypothesis

Does ampicillin-sulbactam have any antichlamydial activity?

Conclusion

Doxycycline and erythromycin effectively eliminate Chlamydia trachomatis, while ampicillin-sulbactam shows good activity but does not completely eradicate the infection.

Supporting Evidence

  • Doxycycline, erythromycin, and clindamycin achieved 100% eradication of inclusions.
  • Ampicillin/sulbactam resulted in a greater than 99% reduction in inclusion count.
  • Clindamycin and ampicillin/sulbactam may provide adequate coverage for chlamydial infections.

Takeaway

This study tested different antibiotics to see how well they can kill a germ called Chlamydia. Some worked really well, while others didn't work as good.

Methodology

Endocervical isolates of C. trachomatis were tested against five antibiotics using McCoy cell monolayers.

Limitations

The study used a high inoculum that may not reflect actual clinical infections.

Participant Demographics

Nonpregnant adolescents and postpartum patients.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication